Blog
Developing new Temozolomide analogs to improve brain tumor patient survival
SIGNIFICANCE Glioblastoma (GBM) is the most common and lethal primary malignant brain tumor in adults. Despite the advances in understanding the molecular mechanism underlying GBM tumorigenesis, most of the current targeted therapies are still ineffective and temozolomide (TMZ) has remained the cornerstone of GBM treatment. Treatment...
Patient Story: Making an Impact in Glioblastoma Treatment
The research arm at Pacific Neuroscience Institute confronts some of medicine’s biggest brain tumor challenges. Read this story about glioblastoma and the innovative clinical trial treatment a patient received.
Nanoparticles as a Next-Generation Drug Delivery In Cancer Treatment
Nanotechnology is a compelling new drug delivery method in oncology where nanoparticles are engineered to target therapeutics to kill cancer. Find out more in Dr. Venkata Yenugonda's review article in the March 2019 issue International Journal of Nanomedicine.
Last updated: April 2nd, 2019